High molecular weight calmodulin-binding protein: 20 years onwards-a potential therapeutic calpain inhibitor

Sreejit Parameswaran1, Rajendra K Sharma

  • 1Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Canada.

Insights

Cardiovascular diseases involve apoptosis, a key factor in heart failure. A novel protein, high molecular weight calmodulin-binding protein (HMWCaMBP), shows promise in protecting heart tissue from damage during ischemia.

Area of Science:

  • Cardiovascular Biology
  • Cellular Proteolysis
  • Apoptosis Mechanisms

Background:

  • Apoptosis contributes significantly to heart failure in cardiovascular diseases.
  • Caspase-independent apoptosis, mediated by calpains and other proteases, is triggered by elevated intracellular Ca(2+) levels.
  • Calpains are Ca(2+)-activated cysteine proteases, and calpastatin is their specific inhibitor.

Purpose of the Study:

  • To review the role of a novel high molecular weight calmodulin-binding protein (HMWCaMBP) in cardiovascular health.
  • To elucidate the function of HMWCaMBP in ischemia-reperfusion injury.
  • To explore the therapeutic potential of HMWCaMBP.

Main Methods:

  • Previous research identified HMWCaMBP in cardiac tissue, showing homology to calpastatins and calpastatin activity.
  • Studies observed decreased HMWCaMBP expression during ischemia due to its susceptibility to calpain proteolysis.
  • Analysis of HMWCaMBP's interaction with calpains and its protective role in normal myocardium.

Main Results:

  • HMWCaMBP exhibits calpastatin activity and homology to known calpastatins.
  • Ischemia-reperfusion leads to increased calpain activity, overwhelming HMWCaMBP and causing proteolysis of HMWCaMBP and other substrates.
  • This proteolysis results in cellular damage, highlighting the detrimental effects of imbalanced calpain/HMWCaMBP activity.

Conclusions:

  • HMWCaMBP may play a protective role against calpain-mediated damage in normal cardiac tissue.
  • During ischemia-reperfusion, calpain activity can exceed HMWCaMBP's inhibitory capacity, leading to cellular injury.
  • Further research is needed to fully understand HMWCaMBP's role and its therapeutic implications in ischemia-reperfusion.